IPHA   $1.35  -2.88% Market Closed

Innate Pharma S.A.

EMA (20): 2026-03-02 the price crossed down the moving average line and formed a short-term downside trend.

EMA (50): 2026-02-03 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (100): 2025-11-12 the price crossed down the moving average line and demonstrates a strong downside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it crossed the signal line from the top and falls. These factors mean that the market confirms the tendency to fall. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: signal line crossed the middle level.

Trend Type flat and down
Power slow
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -4.24%
EMA (20) date of signal March 2, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -11.24%
EMA (50) date of signal Feb. 3, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -17.71%
EMA (100) date of signal Nov. 12, 2025, 3 a.m.
RSI Signals bearish
RSI (14) Yield -8.14%
RSI (14) date of signal Feb. 27, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -4.24%
MACD date of signal March 2, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield 0.0
Stochastic date of signal March 3, 2026, 3 a.m.
Updated March 4, 2026, 8:35 p.m.